Correlation Between Mineralys Therapeutics, and MeiraGTx Holdings

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and MeiraGTx Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and MeiraGTx Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and MeiraGTx Holdings PLC, you can compare the effects of market volatilities on Mineralys Therapeutics, and MeiraGTx Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of MeiraGTx Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and MeiraGTx Holdings.

Diversification Opportunities for Mineralys Therapeutics, and MeiraGTx Holdings

0.11

Correlation Coefficient

Mineralys Therapeutics,  MeiraGTx Holdings

Average diversification

The 3 months correlation between Mineralys and MeiraGTx is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and MeiraGTx Holdings PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MeiraGTx Holdings PLC and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with MeiraGTx Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MeiraGTx Holdings PLC has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and MeiraGTx Holdings go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and MeiraGTx Holdings

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the MeiraGTx Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.03 times less risky than MeiraGTx Holdings. The stock trades about -0.02 of its potential returns per unit of risk. The MeiraGTx Holdings PLC is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  672.00  in MeiraGTx Holdings PLC on October 22, 2024 and sell it today you would lose (46.00) from holding MeiraGTx Holdings PLC or give up 6.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  MeiraGTx Holdings PLC

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

MeiraGTx Holdings PLC

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MeiraGTx Holdings PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MeiraGTx Holdings may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Mineralys Therapeutics, and MeiraGTx Holdings

The main advantage of trading using opposite Mineralys Therapeutics, and MeiraGTx Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, MeiraGTx Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MeiraGTx Holdings will offset losses from the drop in MeiraGTx Holdings' long position.

The idea behind Mineralys Therapeutics, Common and MeiraGTx Holdings PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.